Global Steps for MEF2C Haploinsufficiency Syndrome (MCHS)

Sophia is four years old and lives with the challenges of the rare MEF2C Haploinsufficiency Syndrome (MCHS). She cannot speak and is at the developmental level of a toddler. Many other children with MCHS struggle with epilepsy and difficulty walking – if they can walk at all. But with your support, we can create a therapy that offers Sophia and others a brighter future.

We are thrilled to announce our new fundraising initiative: Global Steps for MCHS!

The MEF2C Foundation, MEF2C Hilfsorganisation e.V. and Rarebird are launching an international effort to fund a clinical readiness study which is crucial for approving a treatment for MEF2C Haploinsufficiency Syndrome. While our global site with Cornell is now online, we need your support to boost the funds for the project and fastrack the work. Any funds donated will feed into the natural history work or the toxicology work which is also critical to demonstrate our clinical trial readiness. We have a global strategy and we are currently working hard to launch our European site to make pave the way and ensure the treatment can get approved globally as quickly as possible.

How you can help:

Together, we can bring a therapy to children with MEF2C around the world.

Thank you for being part of this mission. Together, we can change lives.

Follow us on social media and donate directly via Instagram or Facebook

Visit www.mef2c.de for more details.